A Study of ILB2109 in Patients With Advanced Solid Malignancies
A Study of ILB2109 in Patients With Advanced Solid Malignancies
Active, not recruiting · NCT05278546 · Registry updated 2024-11-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of ILB2109 in Patients With Advanced Solid Malignancies | Advanced Solid Tumor | Active, not recruiting | Phase 1 | 2024-11-12 | NCT05278546 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innolake Biopharm | 2 |
| Shandong Cancer Hospital and Institute | 71 |
| Shanghai East Hospital | 53 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shandong Cancer Hospital and Institute | Jinan | China | 1 |
| Shanghai East Hospital | Shanghai | China | 17 |